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■Introduction
It is well known that overuse of antibiotics can lead
to the emergence of antibiotic-resistant bacteria, and
the treatment of infection caused by multiantibiotic-
resistant bacteria is difficult. The occurrence of
hospital-acquired infections caused by multiantibiotic-
resistant bacteria is becoming a disturbing problem.
Accordingly, proper selection of antibiotics is impor-
tant. It has been demonstrated that a resistant
bacteria may appear when a specific antibiotic is used
frequently and that sensitivity for antibiotic is restored
when the antibiotic is suspended for a period of time.
On the basis of these findings, the concept of antibiotic
heterogeneity was established, in which the emer-
gence of antibiotic-resistant bacteria is controlled by
the impartial use of various antibiotics. As a means of
enabling antibiotic heterogeneity, antibiotic cycling
therapy, a method in which different kinds of antibiot-
ics are sequentially used for a certain period, has been
proposed and its effectiveness in controlling the emer-
gence of resistant bacteria reported１～３）. However,
since few reports of the efficacy of antibiotic cycling
therapy for preventing surgical site infections (SSI)
following cardiac surgery have been presented, it
effectiveness has not been well established. In the
present study, we aimed to clarify the preventive
effects of antibiotic cycling therapy on postoperative
SSI after cardiac surgery.
■Materials and Methods
A total of 618 patients were enrolled in this study
from April 1997 to March 2005. The study population
included patients undergoing elective cardiovascular
surgery at Toyama University Hospital. Patients for
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whom the administration of antibiotics was suspended
or changed due to an allergic reaction to the drugs,
and those who underwent surgery for an infectious
disease such as infectious endocarditis were excluded.
They were divided into two groups in accordance with
the postoperative antibiotic prophylaxis, with those
given cefotiam (2g/day) which was second-generation
cephalosporin and vancomycin (1g/day) concomitantly
immediately before and for seven days after surgery
classified as the Combined group, and those given
antibiotics after surgery for preventing surgical site
infection, which was changed every 3 months in an
antibiotic cycling therapy protocol, classified as the
Cycling group. In the Cycling group, the used
antibiotics were penicillin antibiotics, ampicillin sodium
combined with sulbactam sodium or first- and second-
generation cephalosporin antibiotics, which were
administered immediately before and for 5 days after
cardiac surgery. The study was approved by our
institutional ethics committee, and informed consent
was obtained from each patient with respect to the
surgical method and postoperative care.
Definitions of SSI
The postoperative SSI１） was defined as the occur-
rence of purulent discharge from the surgical wound２）,
localized inflammation of the surgical wound３）, sys-
temic inflammatory reaction of hematological examina-
tion was increased and associated with fever.
Mediastinaitis was defined as criteria reported by
Baskett et al４）. Postoperative infectious complication,
such as pneumonia, urinary tract infection, or biliary
tract infections were not addressed. Necrosis of the
skin due to peripheral circulatory disorder, adiponecro-
sis, and wound disruption associated with undernutri-
tion were considered to exclude SSI.
Statistical analysis
Results for continuous variables were expected as
mean ± standard deviation and categorical variables
were expected as number (percent). The unpaired
Student t test was used to compare the continuous
variables and the Pearson χ2 test was used to compare
the categorical variables between the Cycling group
and the Combined group.
The multivariate logistic regression analysis was
used to assess risk factors for the occurrence of SSI.
First, each variable was compared between patients
with SSI and patients without SSI by the unpaired
Student t test and the Pearson χ2 test. Variables were
considered for the multivariate logistic regression
analysis if their univariable p value was less than 0.20.
Independent variables were assigned odds ratios with
95% confidence intervals, shown together with the
corresponding p value. p value less than 0.05 was
considered statistically significant. SPSS version 12.0J
software (SPSS Japan, Tokyo, JAPAN) was used for all
analyses.
■Results
Comparisons between Combined and Cycling groups
The Combined group consisted of 334 patients
(mean age 64.6 ± 10.8 years), of whom 259 underwent
an isolated coronary artery bypass surgery, 57
received surgery for heart valve diseases, and 18 had
other types of open heart surgeries. The Cycling
group consisted of 284 patients (mean age 66.0 ± 10.2
years), of whom 192 underwent an isolated coronary
artery bypass surgery, 66 received surgery for heart
valve diseases, and 26 had other open heart surgeries.
As for preoperative factors, the prevalence of
hyperlipemia was significantly higher in the Cycling
group (76 patients, 26.8%) as compared to the Com-
bined group (61 patients, 18.3%) (p=0.01). In regard to
surgical factors, the use of a cardiopulmonary pump
was significantly higher in the Cycling group (98
patients, 34.5% v.s. 90 patients, 26.7%, p=0.04). No
significant differences for other factors were observed
between the groups (Table 1).
No statistically significant difference was observed
for the 30-day mortality between the groups, though
the mortality was lower in the Cycling group (2
patients, 0.7% v.s. 8 patients, 2.4%). The incidence of
postoperative SSI was significantly lower in the
Cycling group (3 patients, 0.7%) than in the Combined
group (13 patients, 3.9%) (p=0.027). As for postoperative
SSI that spread to the organs and cavity (mediastinitis,
infection of replacement valve), no significant differ-
ence was observed between the Cycling and Com-
bined groups (4 patients, 1.2% and 2 patients, 0.4%),
respectively. The incidence of SSI caused by antibiotic-
resistant bacteria was significantly lower in the
Cycling group (2 patients, 0.7%, both methicillin−
resistant Staphylococcus aureus) as compared to the
Combined group (10-patients, 3.0%, methicillin−
resistant Staphylococcus aureus in 8 patients,
methicillin−resistant Staphylococcus epidermidis in 1
case, multidrug−resistant Pseudomonas aeruginosa in
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1case) (p=0.04) (Table 2).
Univariate analysis of postoperative SSI incidence
(Table 3)
Antibiotic cycling therapy (p=0.027), previous history
of cerebral infarction (p=0.131), hypertension (p=0.156),
and diabetes mellitus (p=0.26) were found to be factors
involved in the occurrence of postoperative SSI. In
addition, antibiotic cycling therapy (p=0.039), previous
history of cerebral infarction (p=0.193), and hemodialy-
sis (p=0.206) were factors involved in SSI caused by
antibiotic-resistant bacteria.
The multiple logistic regression analysis
Risk factors for occurrence of postoperative SSI,
including age, sex, antibiotic cycling therapy, history of
cerebral infarction, hypertension, diabetes mellitus, and
use of cardiopulmonary bypass, were examined by






Gender, M / F 247 / 87 201/83 0.378
Age (years) 64.6 ± 10.8 66.0 ± 10.2 0.385
Coronary artery bypass surgery 259 (77.5%) 192 (67.6%)
Heart valve surgery 57 (17.1%) 66 (19.8%)
Cardiopulmonary bypass 90 (26.7%) 98 (34.5%) 0.024
Diabetes mellitus 100 (30.0%) 91 (32.0%) 0.573
Hypertension 106 (31.8%) 101 (35.6%) 0.315
Hyperlipidemia 61 (18.3%) 76 (26.8%) 0.011
Previous history of cerebral infarction 46 (13.8%) 32 (11.3%) 0.350
Chronic renal dysfunction 21 (6.3%) 18 (6.3%) 0.979
Hemodialysis 8 (5.4%) 8 (2.8%) 0.742






Mortality 8 (2.4%) 2 (0.7%) 0.097
Hospital stay (days) 35.7 ± 34.1 31.8 ± 19.1 0.143
Surgical site infection 13 (3.9%) 3 (0.7%) 0.027
Surgical site infection of organ and space 4 (1.2%) 2 (0.4%) 0.533
Respiratory infection 1 (0.3%) 3 (1.1%) 0.242
Infection due to antibiotic-resistant bacteria 10 (3.0%) 2 (0.7%) 0.040
Table 3 Comparison of patient characteristics with surgical site infections and infection due to resistant microbial
surgical site infections infection due to antibiotic-resistant bacteria
Yes No p value Yes No p value
Number 16 602 12 606
Gender, M / F 11 / 5 437 / 165 0.734 10 / 2 438 / 168 0.400
Age (years) 67.5 ± 12.0 65.2 ± 10.5 0.385 68.0 ± 12.2 65.2 ± 10.5 0.360
Coronary artery bypass surgery 12 (75.0%) 455 (75.6%) 0.957 9 (75.0%) 458 (75.7%) 0.955
Cardiopulmonary bypass 4 (25.0%) 184 (30.6%) 0.633 3 (25.0%) 184 (30.4%) 0.686
Diabetes mellitus 7 (43.8%) 184 (30.6%) 0.260 4 (33.3%) 187 (30.9%) 0.857
Hypertension 8 (50.0%) 199 (33.1%) 0.156 5 (41.7%) 202 (33.4%) 0.548
Hyperlipidemia 2 (12.5%) 135 (22.4%) 0.346 2 (16.7%) 135 (22.3%) 0.641
Previous history of cerebral infarction 4 (25.0%) 74 (12.3%) 0.131 3 (25.0%) 74 (12.4%) 0.193
Chronic renal dysfunction 2 (12.5%) 37 (6.1%) 0.302 1 (8.3%) 38 (6.3%) 0.772
Hemodialysis 1 (6.3%) 15 (2.5%) 0.350 1 (8.3%) 15 (2.5%) 0.206
Cycling therapy 3 (18.8%) 281 (46.7%) 0.027 2 (16.7%) 282 (46.6%) 0.039
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multiple logistic regression analysis. As a result, only
antibiotic cycling therapy was shown to be an
independent factor, with an odds ratio of 0.2
(confidence interval [CI]: 0.07-0.9, p=0.030) (Table 4).
The same factors were analyzed for the risk of SSI
caused by antibiotic-resistant bacteria, antibiotic
cycling therapy with an odds ratio of 0.2 (CI: 0.05-1.0, p
=0.054), and hemodialysis with an odds ratio of 4.9 (CI:
0.5-45.3, p=0.165), were shown to be significant (Table
5).
■Discussion
The SSI following cardiac surgery is associated with
adverse outcomes. When the infection spreads to
deeper regions, it becomes as serious as mediastinitis.
Further, it has been known that the immune system is
suppressed by use of a cardiopulmonary bypass and
systemic hypothermia is associated with increased
SSI５）. In 2006, the society of thoracic surgeons recom-
mended that the duration for postoperative
administration of prophylactic antibiotics is no longer
than 48 hours, and a beta-lactum antibiotics is
indicated as a single antibiotic of choice for standard
cardiac surgical prophylaxis in usual population６，７）．
However, the patients who have a high incidence of
methicillin−resistant Staphylococcus aureus and the
other antibiotic-resistant bacteria were increasing. The
choice of antibiotic prophylaxis is important to prevent
postoperative SSI in cardiac surgery.
Antibiotic cycling therapy has been proposed as a
method for utilizing antibiotic heterogeneity and its
effectiveness in intensive care unit has been
reported２，３）. Kollef et al.１） introduced antibiotic cycling
therapy to the patients undergoing cardiac surgery, in
which ceftazidime and ciprofloxacin were changed in
turn every 6 months, and reported that the antibiotic
cycling therapy reduced the incidence of postoperative
ventilator-associated pneumonia attributed to antibiotic-
resistant bacteria. Gruson et al.２）also employed antibi-
otic cycling therapy, with a beta-lactam antibiotics,
amino-glycosidic antibiotics, and newquinolones antibi-
otics used in turn, based on their analysis of resistance
patterns of the antibiotics. They reported a decrease in
the incidence of ventilator-associated pneumonia and
improvement of drug sensitivity of Gram-negative
bacteria. Other studies have reported the inhibitory
effects of antibiotic cycling therapy toward infection
with Gram-negative bacteria, such as P. aeruginosa,
Bacillus , and glycopeptide−resistant enterococci８，９，１０）.
For resistant Gram-positive bacteria as well, it was
reported that the incidence was decreased by intro-
duction of antibiotic cycling therapy３，１０）. In our study,
the incidence of postoperative antibiotic-resistant
bacteria decreased in significance by antibiotic cycling
therapy.
The cycle length in antibiotic cycling therapy varies
Table 4 Multivariate analysis of surgical site infections
Odds ratio 95%CI p value
Antibiotic cycling therapy 0.2 0.07-0.9 0.030
Hypertension 1.8 0.7-5.2 0.248
Previous history of cerebral infarction 1.9 0.6-6.5 0.288
Diabetes mellitus 1.7 0.6-4.9 0.318
Age 1.0 1.0-1.1 0.433
Female 0.8 0.3-2.4 0.670
Cardiopulmonary bypass 1.3 0.4-4.5 0.717
Table 5 Multivariate analysis of infection due to antibiotic-resistant bacteria
Odds ratio 95%CI p value
Antibiotic cycling therapy 0.2 0.05-1.0 0.054
Hemodialysis 4.9 0.5-45.3 0.165
Age 1.0 1.0-1.1 0.292
Previous history of cerebral infarction 2.0 0.5-8.0 0.343
Female 2.1 0.4-10.6 0.348
Cardiopulmonary bypass 1.4 0.3-5.9 0.655
Diabetes mellitus 1.0 0.3-3.6 0.979
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widely among reports. Toltzis et al.１１）performed anti-
biotic cycling therapy with a single antibiotic changed
every month in a neonatal intensive care unit and
reported that the detection rate of Gram-negative
bacteria was not different than with the control group.
Further, Merz et al.１２） performed antibiotic cycling
therapy with a cycle length of 3-4 months in an
intensive care unit and reported that no significant
effect on infection was observed. It is considered that
new tolerance might be acquired in some cases when
the cycle length is extended, which would make the
therapy ineffective１３）. The view about the cycle length
is that less than 1 month is too short, while 3 or 4
months is too long２，１４）. In the present study, we
changed the antibiotics every 3 months and obtained
effective results. However, additional studies regarding
the cycle length in antibiotic cycling therapy are
needed.
Study limitations
The present study has a number of limitations. First,
our study was retrospective without randomization.
Second, there may be problems regarding the
unmatched backgrounds of patients contained in the
findings. We consider it desirable to conduct a
randomized prospective study, in which the types of
antibiotics are unified.
■Conclusion
In the present study, we found that the incidence of
SSI following cardiac surgery was reduced following
the introduction of antibiotic cycling therapy. The
multiple logistic regression analysis showed that
antibiotic cycling therapy was an independent factor
to lower the occurrence of postoperative SSI and
incidence of antibiotic-resistant bacteria, and hemo-
dialysis were shown to factors that increased the risk
of SSI caused by antibiotic-resistant bacteria.
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